Hold on to your huaraches: as part of its 65th anniversary, Lilly Pulitzer is dipping a pastel-painted toe into the world of ...

Around the world, Pulitzer Center grantees are reporting on misinformation related to science, climate change, elections, health issues, and fossil fuels. We believe the best way to counter this ...

BIGBANG’s G-Dragon is back—and topping music charts across the globe! On October 31 at 6 p.m. KST, G-Dragon made his long-awaited solo return with his new pre-release single “POWER.” ...

Eli Lilly reported third-quarter results before the market opened on Wednesday. Management missed Wall Street estimates and lowered earnings guidance for 2024. Sales of Zepbound and Mounjaro ...

(AP Photo/Peter Morgan) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] NEW YORK (AP) — U.S. stock indexes edged lower Wednesday after drops for Eli Lilly and chip companies ...

Eli Lilly and Company reported third quarter results ... as the following study from July 2024 or the study from which the chart above was taken. While Novo Nordisk is mostly focused on diabetes ...

Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment ...

Copyright 2024 The Associated Press. All Rights Reserved. FILE - This April 26, 2017 file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. (AP ...

Drug maker Eli Lilly’s share price plunged Wednesday morning after the company reported worse third-quarter results than expected, especially in its weight-loss drug division, registering a rare ...

Eli Lilly has dropped (PDF) the lead candidate from its $2.4 billion takeover of Dice Therapeutics, shifting the focus of its oral IL-17 psoriasis program to a follow-up molecule. Lilly kicked DC ...

Of Lilly’s $3.11 billion in quarterly sales from Mounjaro, $2.4 billion came from the U.S. Related Compounders sue FDA for removing Eli Lilly's tirzepatide from shortage list ...

Eli Lilly (LLY) missed Wall Street's revenue expectations in its third quarter earnings released Wednesday morning, which sent shares down more than 6%. The drugmaker also slashed its profit ...